This site is intended for UK healthcare professionals only.
If you are not a UK healthcare professional, click here.
Approx.
10
mins
This digital resource summarises the key efficacy and safety data from the ECHELON-2 study,3 which investigated ADCETRIS + CHP vs CHOP in adult patients with previously untreated sALCL.
This website is intended for UK healthcare professionals and includes promotional content, medical education and professional support resources about Takeda Oncology products and related therapy areas. This website is developed and funded by Takeda.
©2025 Takeda Pharmaceutical Company Limited. All rights reserved
C-APROM/GB/OG/0115 | March 2025
You will be redirected to an external website that is neither owned or controlled by Takeda Ltd. Takeda does not review, endorse or control the content of any non-Takeda site.
Takeda Ltd is not responsible for the accuracy, content, practices or standards of any non-Takeda resources accessed through a link on this site.
Do you wish to continue?
Do you wish to continue?
